Therapy News and Research

RSS

Sex differences in kidney replacement therapy remain consistent over the last 5 decades

Fewer women than men receive kidney replacement therapy, such as dialysis or kidney transplantation, and a recent analysis from Europe reveals that this difference has remained consistent over the last 5 decades and across countries.

24 Oct 2019

School-based programs have great potential to help adolescents affected by armed conflict

Communities in high income countries around the world continue to receive record-setting numbers of newcomers fleeing armed conflict.

24 Oct 2019

Genetically definable subgroups of cancers sensitive to treatment

Precision oncology aims to use genetic features of a patient's tumor to tailor anti-cancer therapy. DNA mutations in a drug target have provided a number of therapeutic opportunities; however, there are many cancer types that do not have obvious targetable mutations.

24 Oct 2019

Optimal implementation of existing, new interventions essential to end HIV pandemic

Optimal implementation of existing HIV prevention and treatment tools and continued development of new interventions are essential to ending the HIV pandemic, National Institutes of Health experts write in a commentary Clinical Infectious Diseases.

24 Oct 2019

Researchers identify potential approach to stop growth of common brain tumor in children

University of North Carolina Lineberger Comprehensive Cancer Center researchers have identified a potential approach to stop the growth of the most common type of brain tumor in children.

24 Oct 2019

Mon4t, Henry Ford Health System jointly launch pilot study related to AI and Parkinson's disease

Henry Ford Health System and Montfort, an Israeli startup specializing in neurological disorders, have launched a pilot study related to artificial intelligence (AI) and Parkinson's disease. In 2018, Mon4t was the winner of Henry Ford Innovations' first AI challenge

24 Oct 2019

ConvertibleCAR immunotherapy can be used to attack HIV latent reservoir

A team of Gladstone scientists and their partners at Xyphos Biosciences, Inc. describe a new way of attacking cells infected by HIV in this week's issue of the journal Cell.

24 Oct 2019

Study reveals novel druggable driver gene in human gastrointestinal stromal tumors

Sarcomas - cancers that arise from transformed mesenchymal cells (a type of connective tissue) - are quite deadly. Gastrointestinal stromal tumors are the most common human sarcoma and are initiated by activating mutations in the KIT receptor tyrosine kinase.

24 Oct 2019

Behavioral health program has positive impact on employees with depression or anxiety

An employer-sponsored behavioral health program can reduce symptoms in employees with depression and anxiety, reports a study in the October Journal of Occupational and Environmental Medicine.

24 Oct 2019

Metacognitive therapy significantly reduces risk of relapse

Depression is one of the most common mental disorders worldwide. It affects both individuals and society as a whole, in the form of lost work productivity, high mortality and lower quality of life.

24 Oct 2019

Kidney Health Initiative to study patient preferences for novel renal replacement therapy devices

The US Food and Drug Administration has awarded a contract to the Kidney Health Initiative to study patient preferences for innovative renal replacement therapy devices.

24 Oct 2019

MR Solutions launches advanced PET/CT preclinical imaging range at EANM ‘19

MR Solutions has launched a complete range of advanced PET/CT preclinical imaging systems at EANM ‘19, (European Association of Nuclear Medicine) last week in Barcelona. The range comprising four models, including a small benchtop PET/CT, can accommodate small animals up to 12 kg.

24 Oct 2019

Washington State law on behavioral care balances parental rights, teens’ autonomy

When Ben Packard met with the 16-year-old girl a little over a year ago, she was a patient at Seattle Children's Hospital, where she'd been admitted after trying to kill herself. Her parents were distraught.

24 Oct 2019

New NPO formed to accelerate development of therapies for Shankopathies

Parents of children affected by Phelan-McDermid syndrome (PMS) announce the formation of CureSHANK, a nonprofit organization on a mission to accelerate drug development in PMS and other diseases related to the SHANK genes for which there are currently no FDA approved treatments.

23 Oct 2019

Cleveland Clinic announces Top 10 Medical Innovations for 2020

A dual-acting osteoporosis drug. Minimally invasive mitral valve surgery. New treatment for peanut allergies. These are some of the innovations that will enhance healing and change healthcare in the coming year, according to a distinguished panel of doctors and researchers.

23 Oct 2019

NIA-funded study to examine overall benefits and risks of statins in older adults

The National Institute on Aging has funded a major study to examine the overall benefits and risks of cholesterol-lowering drugs known as statins in adults age 75 or older without cardiovascular disease.

23 Oct 2019

Northwestern Medicine launches program to help women understand risk factors for osteoporosis

Loss of bone density is common as women age, particularly around menopause when women lose more bone than they make. When bone density becomes so low that fracture is likely, the condition is called osteoporosis.

23 Oct 2019

Disrupting key immune regulator boosts anti-tumor immunity, enables cancer clearance

The immune system must strike an exquisite balance between vanquishing infections and cancer, while at the same time restraining its activity to avoid inadvertently attacking the body's healthy tissues and organs.

23 Oct 2019

New portable system could allow for better detection of unilateral spatial neglect

Imagine struggling to see, listen, or make movements in half of your environment. This is typical for individuals who suffer from unilateral spatial neglect, a common post-stroke deficit of attention to objects or events on the side opposite of the brain injury. The condition has a major impact on the everyday lives of stroke survivors and has shown to be a strong predictor of disability.

23 Oct 2019

Discovery reveals why newer PD-1 targeted therapies sometimes fail

Researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute report a discovery that helps scientists understand why some tumors lack immune cell infiltration and are therefore unresponsive to newer PD-1 targeted therapies.

23 Oct 2019

Therapy News and Research

Sex differences in kidney replacement therapy remain consistent over the last 5 decades

School-based programs have great potential to help adolescents affected by armed conflict

Genetically definable subgroups of cancers sensitive to treatment

Optimal implementation of existing, new interventions essential to end HIV pandemic

Researchers identify potential approach to stop growth of common brain tumor in children

Mon4t, Henry Ford Health System jointly launch pilot study related to AI and Parkinson's disease

ConvertibleCAR immunotherapy can be used to attack HIV latent reservoir

Study reveals novel druggable driver gene in human gastrointestinal stromal tumors

Behavioral health program has positive impact on employees with depression or anxiety

Metacognitive therapy significantly reduces risk of relapse

Kidney Health Initiative to study patient preferences for novel renal replacement therapy devices

MR Solutions launches advanced PET/CT preclinical imaging range at EANM ‘19

Washington State law on behavioral care balances parental rights, teens’ autonomy

New NPO formed to accelerate development of therapies for Shankopathies

Cleveland Clinic announces Top 10 Medical Innovations for 2020

NIA-funded study to examine overall benefits and risks of statins in older adults

Northwestern Medicine launches program to help women understand risk factors for osteoporosis

Disrupting key immune regulator boosts anti-tumor immunity, enables cancer clearance

New portable system could allow for better detection of unilateral spatial neglect

Discovery reveals why newer PD-1 targeted therapies sometimes fail

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News